KLRS
Kalaris Therapeutics
KLRS
KLRS
84 hedge funds and large institutions have $329M invested in Kalaris Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 27
49% less capital invested
Capital invested by funds: $640M → $329M (-$311M)
Holders
84
Holding in Top 10
–
Calls
$647K
Puts
$321K
Top Buyers
| 1 | +$4.59M | |
| 2 | +$4.24M | |
| 3 | +$2.53M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.42M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.24M |
Top Sellers
| 1 | -$6.72M | |
| 2 | -$4.82M | |
| 3 | -$4.24M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.13M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.93M |